SHARON BLEVINS: Open Payments
NPI 1609549716 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 43 payments from 11 companies in 2025. Trend: 2023 $1,354 · 2024 $1,101 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| AstraZeneca Pharmaceuticals LP | 4 | $220 |
| Exact Sciences Corporation | 4 | $111 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Novo Nordisk Inc | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: FARXIGA, UBRELVY, Cologuard Collection Kit, GEMTESA, QULIPTA, VRAYLAR, AIRSUPRA, LINZESS.
Industry payments across WV — which companies pay providers there.
